Osteosarcoma cell proliferation and migration are partly regulated by redox-activated NHE-1
Background: Osteosarcoma (OS) is the most common primary malignant bone tumor in children and adolescents. OS is associated with locally aggressive growth and high metastatic potential. The mechanisms that underlie these processes are currently elusive. Reactive oxygen species (ROS) and Na+/H+ exchanger 1 (NHE1) have been suggested to regulate proliferation and migration of tumor cells. However, the relationship between NHE1 and ROS in OS proliferation and migration has not been investigated before.
Aim: To investigate the role of NHE1 and ROS in the proliferation and migration of OS.
Methods: ROS levels and NHE1 expression were studied in cultured human OS cells and human OS xenografts in nude mice. In vitro, OS cells were treated with different doses of tert-butyl hydroperoxide (tBHP), a ROS inducer, and cariporide, an NHE1 inhibitor, to study the effect on cell proliferation and migration. In vivo, nude mice bearing OS cells were administrated with NHE1 inhibitor or antioxidant and the tumor weights were measured.
Results: This study reported for the first time that the expression of NHE1 and intracellular ROS level were both increased in OS tissues and cells. Exposure of OS cell to ROS derived from tBHP was able to accelerate cell proliferation and migration and also up-regulate NHE1 protein expression. Moreover, tBHP significantly increased intracellular pH (pHi), decreased extracellular pH (pHe) and induced upregulation of ERK, MMP2, and MMP9. Lowering of ROS levels with the anti-oxidant DMTU or inhibiting NHE1 activity via cariporide abolished the stimulatory effect of tBHP. However, there cariporide did not affect intracellular ROS levels. In vivo study we further confirmed that cariporide could inhibit tumor growth in the nude mouse xenografts of OS cells.
Conclusions: The data demonstrate that up-regulation of NHE1 was induced by low concentrations of ROS contributes to the regulation of tumor proliferation and invasion of OS.
Relevance for patients: There is potential application for cariporide as an effective antitumor agent during the development of human osteosarcoma. In addition, redox modulation on proton transport may represent a novel target of osteosarcoma prevention, and open a new avenues for future research.
[1] He JP, Hao Y, Wang XL, Yang XJ, Shao JF, Guo FJ, Feng JX. Review of the molecular pathogenesis of osteosarcoma. Asian Pac J Cancer Prev 2014; 15: 5967-5976.
[2] Luetke A, Meyers PA, Lewis I, Juergens H. Osteosarcoma treatment - where do we stand? A state of the art review. Cancer Treat Rev 2014; 40: 523-532.
[3] Gillies RJ, Raghunand N, Karczmar GS, Bhujwalla ZM. Mri of the tumor microenvironment. J Magn Reson Imaging 2002; 16: 430-450.
[4] Paradiso A, Cardone RA, Bellizzi A, Bagorda A, Guerra L, Tommasino M, Casavola V, Reshkin SJ. The Na+/H+ exchanger-1 induces cytoskeletal changes involving reciprocal rhoa and rac1 signaling, resulting in motility and invasion in mda-mb435 cells. Breast Cancer Res 2004; 6: R616-628.
[5] Stuwe L, Muller M, Fabian A, Waning J, Mally S, Noel J, Schwab A, Stock C. pH dependence of melanoma cell migration: Protons extruded by nhe1 dominate protons of the bulk solution. J Physiol 2007; 585: 351-360.
[6] Loo SY, Chang MK, Chua CS, Kumar AP, Pervaiz S, Clement MV. Nhe-1: A promising target for novel anti-cancer therapeutics. Curr Pharm Des 2012; 18: 1372-1382.
[7] Malo ME, Fliegel L. Physiological role and regulation of the Na+/H+ exchanger. Can J Physiol Pharmacol 2006; 84: 1081- 1095.
[8] Pedersen SF. The Na+/H+ exchanger nhe1 in stress-induced signal transduction: Implications for cell proliferation and cell death. Pflugers Arch 2006; 452: 249-259.
[9] Schieber M, Chandel NS. Ros function in redox signaling and oxidative stress. Curr Biol 2014; 24: R453-462.
[10] Bauer G. Targeting extracellular ros signaling of tumor cells. Anticancer Res 2014; 34: 1467-1482.
[11] Lopez-Lazaro M. Dual role of hydrogen peroxide in cancer: Possible relevance to cancer chemoprevention and therapy. Cancer Lett 2007; 252: 1-8.
[12] Nicco C, Laurent A, Chereau C, Weill B, Batteux F. Differential modulation of normal and tumor cell proliferation by reactive oxygen species. Biomed Pharmacother 2005; 59: 169-174.
[13] Hu Q, Xia Y, Corda S, Zweier JL, Ziegelstein RC. Hydrogen peroxide decreases phi in human aortic endothelial cells by inhibiting Na+/H+ exchange. Circ Res 1998; 83: 644-651.
[14] Sipos H, Torocsik B, Tretter L, Adam-Vizi V. Impaired regulation of pH homeostasis by oxidative stress in rat brain capillary endothelial cells. Cell Mol Neurobiol 2005; 25: 141-151.
[15] Sabri A, Byron KL, Samarel AM, Bell J, Lucchesi PA. Hydrogen peroxide activates mitogen-activated protein kinases and Na+/H+ exchange in neonatal rat cardiac myocytes. Circ Res 1998; 82: 1053-1062.
[16] Boedtkjer E, Praetorius J, Aalkjaer C. Nbcn1 (slc4a7) mediates the Na+-dependent bicarbonate transport important for regulation of intracellular ph in mouse vascular smooth muscle cells. Circ Res 2006; 98: 515-523.
[17] Thomas JA, Buchsbaum RN, Zimniak A, Racker E. Intracellular pH measurements in Ehrlich ascites tumor cells utilizing spectroscopic probes generated in situ. Biochemistry 1979; 18: 2210-2218.
[18] Yang X, Wang D, Dong W, Song Z, Dou K. Inhibition of Na(+)/H(+) exchanger 1 by 5-(n-ethyl-n-isopropyl) amiloride reduces hypoxia-induced hepatocellular carcinoma invasion and motility. Cancer Lett 2010; 295: 198-204.
[19] Martinez-Zaguilan R, Seftor EA, Seftor RE, Chu YW, Gillies RJ, Hendrix MJ. Acidic pH enhances the invasive behavior of human melanoma cells. Clin Exp Metastasis 1996; 14: 176-186.
[20] Webb BA, Chimenti M, Jacobson MP, Barber DL. Dysregulated pH: a perfect storm for cancer progression. Nat Rev Cancer 2011; 11: 671-677.
[21] Reshkin SJ, Cardone RA, Harguindey S. Na+/H+ exchanger, pH regulation and cancer. Recent Pat Anticancer Drug Discov 2013; 8: 85-99.
[22] Yang X, Wang D, Dong W, Song Z, Dou K. Over-expression of Na+/H+ exchanger 1 and its clinicopathologic significance in hepatocellular carcinoma. Med Oncol 2010; 27: 1109-1113.
[23] Yang X, Wang D, Dong W, Song Z, Dou K. Expression and modulation of Na(+) /H(+) exchanger 1 gene in hepatocellular carcinoma: a potential therapeutic target. J Gastroenterol Hepatol 2011; 26: 364-370.
[24] Broadhead ML, Clark JC, Myers DE, Dass CR, Choong PF. The molecular pathogenesis of osteosarcoma: a review. Sarcoma 2011; 2011: 959248.
[25] Liu L, Schlesinger PH, Slack NM, Friedman PA, Blair HC. High capacity Na+/H+ exchange activity in mineralizing osteoblasts. J Cell Physiol 2011; 226: 1702-1712.
[26] Arnett TR. Extracellular pH regulates bone cell function. J Nutr 2008; 138: 415S-418S.
[27] Giorgio M, Trinei M, Migliaccio E, Pelicci PG. Hydrogen peroxide: a metabolic by-product or a common mediator of ageing signals? Nat Rev Mol Cell Biol 2007; 8: 722-728.
[28] Goldstein BJ, Mahadev K, Wu X. Redox paradox: Insulin action is facilitated by insulin-stimulated reactive oxygen species with multiple potential signaling targets. Diabetes 2005; 54: 311-321.
[29] Xue J, Zhou D, Yao H, Gavrialov O, McConnell MJ, Gelb BD, Haddad GG. Novel functional interaction between Na+/H+ exchanger 1 and tyrosine phosphatase SHP-2. Am J Physiol Regul Integr Comp Physiol 2007; 292: R2406-2416.
[30] Burdon RH. Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Radic Biol Med 1995; 18: 775-794.
[31] Riemann A, Ihling A, Schneider B, Gekle M, Thews O. Impact of extracellular acidosis on intracellular pH control and cell signaling in tumor cells. Adv Exp Med Biol 2013; 789: 221-228.
[32] Lamonte G, Tang X, Chen JL, Wu J, Ding CK, Keenan MM, Sangokoya C, Kung HN, Ilkayeva O, Boros LG, Newgard CB, Chi JT. Acidosis induces reprogramming of cellular metabolism to mitigate oxidative stress. Cancer Metab 2013; 1: 23.
[33] Amith SR, Fliegel L. Regulation of the Na+/H+ exchanger (NHE1) in breast cancer metastasis. Cancer Res 2013; 73: 1259-1264.
[34] Tennant DA, Duran RV, Gottlieb E. Targeting metabolic transformation for cancer therapy. Nat Rev Cancer 2010; 10: 267-277.
[35] Parks SK, Chiche J, Pouyssegur J. Disrupting proton dynamics and energy metabolism for cancer therapy. Nat Rev Cancer 2013; 13: 611-623.
[36] Bocanegra V, Gil Lorenzo AF, Cacciamani V, Benardon ME, Costantino VV, Valles PG. RhoA and MAPK signal transduction pathways regulate NHE1-dependent proximal tubule cell apoptosis after mechanical stretch. Am J Physiol Renal Physiol 2014; 307: F881-889.
[37] Zeng ZS, Cohen AM, Guillem JG. Loss of basement membrane type IV collagen is associated with increased expression of metalloproteinases 2 and 9 (MMP-2 and MMP-9) during human colorectal tumorigenesis. Carcinogenesis 1999; 20: 749-755.
[38] Suzuki A, Maeda T, Baba Y, Shimamura K, Kato Y. Acidic extracellular pH promotes epithelial mesenchymal transition in Lewis lung carcinoma model. Cancer Cell Int 2014; 14: 129.
[39] Kato Y, Lambert CA, Colige AC, Mineur P, Noel A, Frankenne F, Foidart JM, Baba M, Hata R, Miyazaki K, Tsukuda M. Acidic extracellular pH induces matrix metalloproteinase-9 expression in mouse metastatic melanoma cells through the phospholipase D-mitogen-activated protein kinase signaling. J Biol Chem 2005; 280: 10938-10944.